why choose us

First received: July 06, 2023

Clinical Trial: Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: OSA

Study Type: INTERVENTIONAL


Official Title: Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea

Brief Summary: Current therapies available for obstructive sleep apnea (OSA) have varying degrees of efficacy due to the complex nature of the disorder.A reduction in pharyngeal muscle activity characterizes OSA, and recent research has shown that combining atomoxetine and oxybutynin improves OSA severity.Thus this may be a viable treatment option.However, the specific effects of these agents alone and in combination on pharyngeal muscle activity remain unknown.The current study will look at the impact of each drug on pharyngeal…

Read more